Concepedia

Loretta M. Cox

LM

Statistics

Publications

9

Citations

962

H-Index

9

Active since

1995

Affiliations

Pfizer (United States)(Current)

Loretta M. Cox is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and drug metabolism.

Publications per year

1995–2022

9

Publications

9

THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL

Angela C. Doran, R. Scott Obach, Bill J. Smith et al. · Drug Metabolism and Disposition · 2004 · 440 citations

Medicine, Pharmacokinetics, Pharmacology +16

SERTRALINE IS METABOLIZED BY MULTIPLE CYTOCHROME P450 ENZYMES, MONOAMINE OXIDASES, AND GLUCURONYL TRANSFERASES IN HUMAN: AN IN VITRO STUDY

R. Scott Obach, Loretta M. Cox, Larry M. Tremaine · Drug Metabolism and Disposition · 2004 · 216 citations

Medicine, Pharmacokinetics, Pharmacology +17

Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug

Jonathan Bauman, Kosea S. Frederick, Aarti Sawant et al. · Drug Metabolism and Disposition · 2008 · 83 citations

Medicine, Pharmacology, Toxicology +17

Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.

Bruce D. Gitter, Robert F. Bruns, J. Jeffry Howbert et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 60 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Design and Discovery of a Selective Small Molecule κ Opioid Antagonist (2-Methyl-<i>N</i>-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF-4455242)

Patrick R. Verhoest, Aarti Sawant Basak, Vinod D. Parikh et al. · Journal of Medicinal Chemistry · 2011 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 9